LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Gross Margin (2025 - 2026)

Updated

LENZ Therapeutics (LENZ) recorded Gross Margin of 94.90% in Q2 2026, down 5.10 percentage points from 100.00% a year earlier but up 51.50 percentage points from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Gross Margin (2025 - 2026) Analysis & Trends

On a TTM basis, LENZ Therapeutics' Gross Margin came in at 51.37% as of Jun 30, 2026; for FY2025, it was 97.81%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn 86.58%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 86.58%
Jun 30, 2026 94.90%
Mar 31, 2026 43.40%
Dec 31, 2025 73.68%
Sep 30, 2025 100.00%
Jun 30, 2025 100.00%
API Access

LENZ Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=LENZ&period=max&api_key=YOUR_API_KEY